The Valley Desk

NCT03273153 · Interventional trial

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

Overall registry status Terminated

Phase 3

Conditions Advanced BRAFV600 Wild-type Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov